BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

10885

0

JFLLIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

JFL LIFE SCIENCES LIMITED performance

Today’s low

Today’s high

₹ 13.75 ₹ 13.75
₹ 13.10

52 week low

52 week high

₹ 11.85 ₹ 37.15
₹ 13.10

Open Price

₹ 13.75

Prev. Close

₹ 13.10

Volume (Shares)

72000.00

Total traded value

₹ 9.43

Upper Circuit

₹ 13.75

Lower Circuit

₹ 12.45

info

JFL LIFE SCIENCES LIMITED Share Price Update

As of the latest trading session, JFL LIFE SCIENCES LIMITED share price is currently at ₹ 13.75, which is up by ₹ 0.64 from its previous closing. Today, the stock has fluctuated between ₹ 13.75 and ₹ 13.75. Over the past year, JFL LIFE SCIENCES LIMITED has achieved a return of -43.82 %. In the last month alone, the return has been -3.84 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

JFL LIFE SCIENCES LIMITED fundamentals


  • Market cap (Cr)

    43.20

  • P/E Ratio (TTM)

    13.59

  • Beta

    -0.20

  • Book Value / share

    11.95

  • Return on equity

    11.09%

  • EPS (TTM)

    0.92

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.75

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

JFL LIFE SCIENCES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 11.59
Operating Expense 10.16
Net Profit 0.75
Net Profit Margin (%) 6.47
Earnings Per Share (EPS) 0.23
EBITDA 1.93
Effective Tax Rate (%) 47.55
Particulars MAR 2025 (Values in Cr)
Revenue 11.73
Operating Expense 11.04
Net Profit 0.08
Net Profit Margin (%) 0.68
Earnings Per Share (EPS) 0.03
EBITDA 1.38
Effective Tax Rate (%) 88.40
Particulars DEC 2024 (Values in Cr)
Revenue 21.25
Operating Expense 20.25
Net Profit 0.74
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 0.22
EBITDA 1.34
Effective Tax Rate (%) 25.25
Particulars SEP 2024 (Values in Cr)
Revenue 39.51
Operating Expense 0.00
Net Profit 1.45
Net Profit Margin (%) 3.66
Earnings Per Share (EPS) 1.32
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 9.54
Operating Expense 6.99
Net Profit 1.91
Net Profit Margin (%) 20.02
Earnings Per Share (EPS) 1.74
EBITDA 3.06
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 82.04
Operating Expense 75.92
Net Profit 4.16
Net Profit Margin (%) 5.07
Earnings Per Share (EPS) 1.26
EBITDA 8.20
Effective Tax Rate (%) 32.24
Particulars MAR 2024 (Values in Cr)
Revenue 46.55
Operating Expense 43.26
Net Profit 3.30
Net Profit Margin (%) 7.08
Earnings Per Share (EPS) 1.00
EBITDA 5.09
Effective Tax Rate (%) 12.92
Particulars MAR 2023 (Values in Cr)
Revenue 42.83
Operating Expense 40.75
Net Profit 2.81
Net Profit Margin (%) 6.56
Earnings Per Share (EPS) 2.90
EBITDA 5.57
Effective Tax Rate (%) 24.46
Particulars MAR 2022 (Values in Cr)
Revenue 33.59
Operating Expense 30.68
Net Profit 2.81
Net Profit Margin (%) 8.36
Earnings Per Share (EPS) 4.12
EBITDA 6.25
Effective Tax Rate (%) 26.05
Particulars MAR 2021 (Values in Cr)
Revenue 32.77
Operating Expense 32.12
Net Profit 0.54
Net Profit Margin (%) 1.64
Earnings Per Share (EPS) 10.90
EBITDA 2.26
Effective Tax Rate (%) 26.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 11.96
ROE % 11.09
ROCE % 15.77
Total Debt to Total Equity 0.22
EBITDA Margin 10.01
Particulars MAR 2024 (Values in Cr)
Book Value / Share 32.35
ROE % 9.73
ROCE % 11.49
Total Debt to Total Equity 0.19
EBITDA Margin 10.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 29.34
ROE % 12.90
ROCE % 15.42
Total Debt to Total Equity 0.53
EBITDA Margin 12.98
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.08
ROE % 30.93
ROCE % 23.10
Total Debt to Total Equity 1.80
EBITDA Margin 18.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 138.28
ROE % 8.82
ROCE % 10.23
Total Debt to Total Equity 2.13
EBITDA Margin 6.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 71.91
Total Liabilities 71.91
Total Equity 39.45
Share Outstanding 32995323
Price to Book Ratio 1.46
Return on Assets (%) 5.78
Return on Capital (%) 8.31
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 56.71
Total Liabilities 56.71
Total Equity 35.57
Share Outstanding 10998441
Price to Book Ratio 1.22
Return on Assets (%) 5.81
Return on Capital (%) 8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 49.05
Total Liabilities 49.05
Total Equity 32.26
Share Outstanding 10998441
Price to Book Ratio 1.12
Return on Assets (%) 5.72
Return on Capital (%) 7.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 48.26
Total Liabilities 48.26
Total Equity 11.29
Share Outstanding 8020441
Price to Book Ratio 0.00
Return on Assets (%) 5.82
Return on Capital (%) 10.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 29.00
Total Liabilities 29.00
Total Equity 6.87
Share Outstanding 496957
Price to Book Ratio 0.00
Return on Assets (%) 1.86
Return on Capital (%) 2.29
Particulars MAR 2025 (Values in Cr)
Net Income 6.13
Cash from Operations -2.50
Cash from Investing -0.01
Cash from Financing 3.54
Net change in Cash 0.00
Free Cash Flow -2.11
Particulars MAR 2024 (Values in Cr)
Net Income 3.79
Cash from Operations 8.47
Cash from Investing -6.08
Cash from Financing -2.34
Net change in Cash -0.02
Free Cash Flow 14.59
Particulars MAR 2023 (Values in Cr)
Net Income 3.71
Cash from Operations -8.07
Cash from Investing 0.87
Cash from Financing 8.07
Net change in Cash -0.12
Free Cash Flow -8.07
Particulars MAR 2022 (Values in Cr)
Net Income 3.80
Cash from Operations 2.19
Cash from Investing -0.71
Cash from Financing -1.46
Net change in Cash 0.15
Free Cash Flow 3.88
Particulars MAR 2021 (Values in Cr)
Net Income 0.74
Cash from Operations -5.77
Cash from Investing -1.64
Cash from Financing 7.24
Net change in Cash -0.26
Free Cash Flow -4.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.64 13.32 1.78 250.13 30.00 / 68.00
BLISS GVS PHARMA LTD 153.05 15.17 1.53 1616.97 105.05 / 190.65
CIPLA LTD 1583.75 23.72 4.10 127929.89 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 272.05 7.66 2.20 800.67 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2750.25 49.20 23.87 46590.89 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.64 17.74 5.15 250.13 30.00 / 68.00
AMRUTAJAN HEALTH LTD 715.65 37.95 6.33 2068.99 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9290.25 109.83 30.14 23225.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 153.05 22.91 1.52 1616.97 105.05 / 190.65

JFL LIFE SCIENCES LIMITED shareholding pattern

Holding

Others
32.53%
Promoter Holdings
67.46%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Smiral Ashwinkumar Patel 1.462563E7 (44.33%) Shareholding of Promoter and Promoter Group
Tejal Smiral Patel 5471154.0 (16.58%) Shareholding of Promoter and Promoter Group
Smiral Ashwinkumar Patel Huf 1314222.0 (3.98%) Shareholding of Promoter and Promoter Group
Pratik Rajendrabhai Gandhi 402000.0 (1.22%) Public Shareholding
Ashwinbhai Jivrambhai Patel 293007.0 (0.89%) Shareholding of Promoter and Promoter Group
Patel Dakshaben 122070.0 (0.37%) Shareholding of Promoter and Promoter Group
Rupesh Kirtibhai Patel 110760.0 (0.34%) Shareholding of Promoter and Promoter Group
Ashokkumar Parshottamdas Patel 89700.0 (0.27%) Shareholding of Promoter and Promoter Group
Ushaben Ashokkumar Patel 70200.0 (0.21%) Shareholding of Promoter and Promoter Group
Artiben Manishkumar Patel 67470.0 (0.2%) Shareholding of Promoter and Promoter Group
Shobhnaben Kirtikumar Patel 58110.0 (0.18%) Shareholding of Promoter and Promoter Group
Kirtikumar Parshottambhai Patel 39000.0 (0.12%) Shareholding of Promoter and Promoter Group

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

JFL LIFE SCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
13.10 4.79 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 12.40
  • 26 Days 12.80
  • 10 Days 12.40
  • 50 Days 13.50
  • 12 Days 12.50
  • 100 Days 15.10
  • 20 Days 12.70
  • 200 Days 16.60
12.50 PIVOT

First Support

12.50

First Resistance

12.50

Second Support

12.50

Second Resistance

12.50

Third Support

12.50

Third Resistance

12.50

RSI

43.34

ADX

41.47

MACD

-0.35

Williams % R

-40.91

Commodity Channel Index (CCI)

-22.75

Date

2025-10-24

Week

15000.00

Same Day

6000.00

Month

18333.00

1 Year

-0.21

3 Year

0.38

Over 1 Month

-3.84%

down

Over 1 Year

-43.82%

down

Over 3 Months

-19.35%

down

Over 3 Years

-5.32%

down

Over 6 Months

-38.87%

down

Over 5 Years

0.00%

down

JFL LIFE SCIENCES LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
13 Sep 2024 0.25 Final 16 Sep 2024 Equity shares
Ex-Date Ex-Bonus Ratio
24 Sep 2024 24 Sep 2024 2:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

JFL LIFE SCIENCES LIMITED Share Price

JFL Life Sciences Limited was incorporated as JFL Life Sciences Private Limited' on April 25, 2010 as a Private Limited Company. Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited', on March 3, 2022. The Company manufactures and market pharmaceutical products. Its product portfolio consists of Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and Capsules (general) and Oral Rehydration Solutions (ORS).

Head quartered in Ahmedabad, Gujarat, Company is engaged in the business of manufacturing of pharmaceutical products. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its
competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad.

In August 2022, the Company launched an IPO of 29,78,000 Equity Shares by raising funds aggregating to Rs. 18.16 Crore.

The Company export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The Company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of the products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.

For the purpose of identification equipment / machinery / containers are appropriately labelled to identify the stage of process. In case of tablets, the materials are quarantined after granulation, compression, coating and final packing operations for clearance from Q.A. before pursuing the next stage of process. In case of capsule, the materials are quarantined after mixing, filling and final packing operation for clearance from Q.A. before pursuing the next stage of process. Containers are labelled as UNDER TEST' with details such as name, code number, quantity, no of containers, manufacturer's name, material code no, and material is then quarantined. A Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion.

Parent organization Indian Private
NSE symbol JFLLIFE
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of JFL Life Sciences Ltd?

Answer Field

JFL Life Sciences Ltd share price is for NSE ₹ 13.75 & for BSE ₹ 0.00 as on Oct 28 2025 09:15 AM.

What is the Market Cap of JFL Life Sciences Ltd Share?

Answer Field

The market cap of JFL Life Sciences Ltd for NSE ₹ 43.20 & for BSE ₹ 0.00 as on Oct 28 2025 09:15 AM.

What is the 52 Week High and Low of JFL Life Sciences Ltd?

Answer Field

The 52 Week High and Low of JFL Life Sciences Ltd for NSE is ₹ 37.15 and ₹ 11.85 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for JFL Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been -43.82%.

What is the P/E Ratio of JFL Life Sciences Ltd Share?

Answer Field

As on Oct 28 2025 09:15 AM the price-to-earnings (PE) ratio for JFL Life Sciences Ltd share is 13.59.

What is the PB ratio of JFL Life Sciences Ltd Share?

Answer Field

As on Oct 28 2025 09:15 AM, the price-to-book (PB) ratio for JFL Life Sciences Ltd share is 11.95.

How to Buy JFL Life Sciences Ltd Share?

Answer Field

You can trade in JFL Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy JFL Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy JFL Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “JFL Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59